ALDH1L2TAMHCC

Jiajun Li1, Chi Zhang1, Qingqing Zhou1

  • 1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

概括

脱酶1家族成员L2 (ALDH1L2) 通过激活NRF2/IL-6/STAT3信号,促进肝细胞癌 (HCC) 的进展和转移. 向ALDH1L2可能会提高HCC治疗中索拉芬尼的疗效.